FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3138924727> ?p ?o ?g. }

• W3138924727 endingPage "175346662096169" @default.
• W3138924727 startingPage "175346662096169" @default.
• W3138924727 abstract "Background: Chronic obstructive pulmonary disease (COPD) is often accompanied by psychiatric problems, such as depression and anxiety, affecting both treatment outcomes and mortality. Evidence for the number of COPD patients using medication for these disorders is sparse. In this study, chronic antidepressant (ATD) and anxiolytic (ANX) drug use – to identify depression and anxiety – among COPD patients was compared with subjects with or without other chronic diseases. Methods: The NControl database containing prescription data of 800 pharmacies including 7 million individuals in The Netherlands was used. Patients of age 55+ years who received frequent prescriptions – at least two/year in 5 out of 6 years – for COPD medication, dermatological drugs, disease-modifying antirheumatic drugs (DMARDs), statins and oral glucose-lowering medication were analyzed for concomitant chronic use of ATDs and ANXs between 1 January 2013 and 1 January 2019. All other subjects aged 55+ years were included as a control group (control group 1). This group was further stratified into a group of subjects that received frequent prescriptions of any kind (control group 2). Results: 15.2% of the patients that receive COPD treatment ( n = 96,319), 15.3% of subjects that are treated for dermatological problems ( n = 62,865), 13.2% of subjects that receive DMARDs ( n = 7900), 11.6% of statins users ( n = 422,376) and 11.4% of oral glucose-lowering medication users ( n = 165,975) are also chronically treated for depression or anxiety, compared with 2.6% (control group 1; n = 3,290,608) and 11.4% (control group 2; n = 757,947). In general, female and 75+ years aged subjects showed a higher risk for using ATDs and ANXs chronically. In the COPD and the dermatological patient group the risk was the highest compared with the other patient groups. Conclusions: The rates of chronic ATD and ANX use and the risk of having depression and/or anxiety are especially high in COPD patients, indicating that psychiatric problems are more common in COPD than in most other chronic diseases. In general, age and gender strongly influence the risk of chronically using ATDs and ANXs. The reviews of this paper are available via the supplemental material section." @default.
• W3138924727 created "2021-03-29" @default.
• W3138924727 creator A5006253107 @default.
• W3138924727 creator A5018590706 @default.
• W3138924727 creator A5023267835 @default.
• W3138924727 creator A5027955015 @default.
• W3138924727 creator A5052916600 @default.
• W3138924727 creator A5069659223 @default.
• W3138924727 date "2021-01-01" @default.
• W3138924727 modified "2023-09-27" @default.
• W3138924727 title "Higher prescription of antidepressants and/or anxiolytics among chronic obstructive pulmonary disease patients" @default.
• W3138924727 cites W1270972813 @default.
• W3138924727 cites W1490028980 @default.
• W3138924727 cites W1571047100 @default.
• W3138924727 cites W1965750866 @default.
• W3138924727 cites W1969227156 @default.
• W3138924727 cites W2016631812 @default.
• W3138924727 cites W2045616259 @default.
• W3138924727 cites W2047672321 @default.
• W3138924727 cites W2056142446 @default.
• W3138924727 cites W2072537723 @default.
• W3138924727 cites W2118862186 @default.
• W3138924727 cites W2123731873 @default.
• W3138924727 cites W2132815673 @default.
• W3138924727 cites W2134989783 @default.
• W3138924727 cites W2150940722 @default.
• W3138924727 cites W2160217804 @default.
• W3138924727 cites W2161243447 @default.
• W3138924727 cites W2170812350 @default.
• W3138924727 cites W2195424142 @default.
• W3138924727 cites W2415908142 @default.
• W3138924727 cites W2418872436 @default.
• W3138924727 cites W2570608423 @default.
• W3138924727 cites W2791249149 @default.
• W3138924727 cites W2804806966 @default.
• W3138924727 cites W2896687116 @default.
• W3138924727 cites W2942007706 @default.
• W3138924727 cites W2982248805 @default.
• W3138924727 doi "https://doi.org/10.1177/1753466620961696" @default.
• W3138924727 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8093612" @default.
• W3138924727 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33752539" @default.
• W3138924727 hasPublicationYear "2021" @default.
• W3138924727 type Work @default.
• W3138924727 sameAs 3138924727 @default.
• W3138924727 citedByCount "2" @default.
• W3138924727 countsByYear W31389247272022 @default.
• W3138924727 countsByYear W31389247272023 @default.
• W3138924727 crossrefType "journal-article" @default.
• W3138924727 hasAuthorship W3138924727A5006253107 @default.
• W3138924727 hasAuthorship W3138924727A5018590706 @default.
• W3138924727 hasAuthorship W3138924727A5023267835 @default.
• W3138924727 hasAuthorship W3138924727A5027955015 @default.
• W3138924727 hasAuthorship W3138924727A5052916600 @default.
• W3138924727 hasAuthorship W3138924727A5069659223 @default.
• W3138924727 hasBestOaLocation W31389247271 @default.
• W3138924727 hasConcept C118552586 @default.
• W3138924727 hasConcept C126322002 @default.
• W3138924727 hasConcept C139719470 @default.
• W3138924727 hasConcept C162324750 @default.
• W3138924727 hasConcept C1862650 @default.
• W3138924727 hasConcept C2426938 @default.
• W3138924727 hasConcept C2776780178 @default.
• W3138924727 hasConcept C2776867660 @default.
• W3138924727 hasConcept C2777765862 @default.
• W3138924727 hasConcept C2779177272 @default.
• W3138924727 hasConcept C2779384505 @default.
• W3138924727 hasConcept C2992779976 @default.
• W3138924727 hasConcept C558461103 @default.
• W3138924727 hasConcept C71924100 @default.
• W3138924727 hasConcept C98274493 @default.
• W3138924727 hasConceptScore W3138924727C118552586 @default.
• W3138924727 hasConceptScore W3138924727C126322002 @default.
• W3138924727 hasConceptScore W3138924727C139719470 @default.
• W3138924727 hasConceptScore W3138924727C162324750 @default.
• W3138924727 hasConceptScore W3138924727C1862650 @default.
• W3138924727 hasConceptScore W3138924727C2426938 @default.
• W3138924727 hasConceptScore W3138924727C2776780178 @default.
• W3138924727 hasConceptScore W3138924727C2776867660 @default.
• W3138924727 hasConceptScore W3138924727C2777765862 @default.
• W3138924727 hasConceptScore W3138924727C2779177272 @default.
• W3138924727 hasConceptScore W3138924727C2779384505 @default.
• W3138924727 hasConceptScore W3138924727C2992779976 @default.
• W3138924727 hasConceptScore W3138924727C558461103 @default.
• W3138924727 hasConceptScore W3138924727C71924100 @default.
• W3138924727 hasConceptScore W3138924727C98274493 @default.
• W3138924727 hasLocation W31389247271 @default.
• W3138924727 hasLocation W31389247272 @default.
• W3138924727 hasLocation W31389247273 @default.
• W3138924727 hasOpenAccess W3138924727 @default.
• W3138924727 hasPrimaryLocation W31389247271 @default.
• W3138924727 hasRelatedWork W1989047233 @default.
• W3138924727 hasRelatedWork W2001913048 @default.
• W3138924727 hasRelatedWork W2399217294 @default.
• W3138924727 hasRelatedWork W2413421841 @default.
• W3138924727 hasRelatedWork W2616191938 @default.
• W3138924727 hasRelatedWork W2895926441 @default.
• W3138924727 hasRelatedWork W2969901322 @default.
• W3138924727 hasRelatedWork W2981715653 @default.

• next